Raymond James Financial Services Advisors’s Profound Medical PROF Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $6.05M | Buy |
|
|||||
|
2024
Q2 | $5.72M | Buy |
|
|||||
|
2024
Q1 | $5.34M | Buy |
|
|||||
|
2023
Q4 | $5.29M | Buy |
|
|||||
|
2023
Q3 | $5.62M | Sell |
|
|||||
|
2023
Q2 | $7.56M | Buy |
|
|||||
|
2023
Q1 | $4.76M | Buy |
|
|||||
|
2022
Q4 | $3.46M | Buy |
|
|||||
|
2022
Q3 | $149K | Sell |
|
|||||
|
2022
Q2 | $272K | Sell |
|
|||||
|
2022
Q1 | $422K | Buy |
|
|||||
|
2021
Q4 | $436K | Sell |
|
|||||
|
2021
Q3 | $1.05M | Buy |
|
|||||
|
2021
Q2 | $980K | Sell |
|
|||||
|
2021
Q1 | $1.21M | Buy |
|
|||||
|
2020
Q4 | $1.17M | Buy |
|
|||||
|
2020
Q3 | $751K | Buy |
|
|||||
|
2020
Q2 | $192K | Sell |
|
|||||
|
2020
Q1 | $148K | Buy |
|